SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031256
Filing Date
2022-11-10
Accepted
2022-11-10 09:20:34
Documents
69
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 910603
2 ex31-1.htm EX-31.1 11425
3 ex31-2.htm EX-31.2 10753
4 ex32-1.htm EX-32.1 4545
  Complete submission text file 0001493152-22-031256.txt   4251370

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pulm-20220930.xsd EX-101.SCH 37639
6 XBRL CALCULATION FILE pulm-20220930_cal.xml EX-101.CAL 52760
7 XBRL DEFINITION FILE pulm-20220930_def.xml EX-101.DEF 133870
8 XBRL LABEL FILE pulm-20220930_lab.xml EX-101.LAB 302421
9 XBRL PRESENTATION FILE pulm-20220930_pre.xml EX-101.PRE 229146
63 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 577574
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 221375296
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences